| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.18▲ | 1.18▲ | 1.17▲ | 1.17▲ | 1.19▼ |
| MA10 | 1.18▲ | 1.18▲ | 1.18▲ | 1.19▼ | 1.22▼ |
| MA20 | 1.18▲ | 1.18▲ | 1.19▼ | 1.18▲ | 1.39▼ |
| MA50 | 1.19▼ | 1.19▼ | 1.19▼ | 1.26▼ | 2.25▼ |
| MA100 | 1.18▲ | 1.13▲ | 1.12▲ | 1.41▼ | 6.17▼ |
| MA200 | 1.12▲ | 1.18▲ | 1.31▼ | 1.77▼ | 246.08▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.000▼ | -0.002▼ | 0.008▲ | 0.077▲ |
| RSI | 50.704▲ | 50.468▲ | 50.322▲ | 48.662▼ | 36.800▼ |
| STOCH | 46.667 | 41.111 | 33.333 | 31.340 | 14.897▼ |
| WILL %R | -46.667 | -46.667 | -46.667 | -46.875 | -90.169▼ |
| CCI | 39.292 | 52.299 | 46.108 | -89.428 | -56.187 |
|
Tuesday, December 23, 2025 04:27 AM
An announcement from RedHill Biopharma ( ($RDHL) ) is now available. On December 19, 2025, RedHill Biopharma entered into a Standby Equity ...
|
|
Tuesday, February 04, 2025 02:26 PM
(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...
|
|
Monday, October 14, 2024 05:26 AM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/12/25 | 1.10 | 1.23 | 1.10 | 1.185 | 200,158 |
| 22/12/25 | 1.14 | 1.18 | 1.14 | 1.15 | 22,905 |
| 19/12/25 | 1.177 | 1.20 | 1.17 | 1.18 | 20,372 |
| 18/12/25 | 1.17 | 1.20 | 1.15 | 1.15 | 51,786 |
| 17/12/25 | 1.22 | 1.2404 | 1.16 | 1.168 | 36,217 |
| 16/12/25 | 1.24 | 1.24 | 1.19 | 1.205 | 61,886 |
| 15/12/25 | 1.22 | 1.22 | 1.14 | 1.19 | 185,461 |
| 12/12/25 | 1.2194 | 1.2196 | 1.1835 | 1.205 | 41,198 |
| 11/12/25 | 1.1939 | 1.2014 | 1.1801 | 1.1999 | 25,650 |
| 10/12/25 | 1.2026 | 1.26 | 1.20 | 1.22 | 78,257 |
|
|
||||
|
|
||||
|
|